Press coverage about Align Technology (NASDAQ:ALGN) has been trending somewhat positive recently, Accern Sentiment reports. The research group ranks the sentiment of news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Align Technology earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave media headlines about the medical equipment provider an impact score of 46.5765009994645 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
These are some of the news articles that may have impacted Accern’s scoring:
Several equities analysts have recently issued reports on ALGN shares. Robert W. Baird restated a “buy” rating and set a $245.00 target price on shares of Align Technology in a research report on Friday, October 27th. Leerink Swann restated an “outperform” rating and set a $250.00 target price on shares of Align Technology in a research report on Friday, October 27th. Credit Suisse Group restated an “outperform” rating and set a $276.00 target price (up from $261.00) on shares of Align Technology in a research report on Tuesday, November 28th. Deutsche Bank started coverage on Align Technology in a research report on Friday, December 8th. They set a “hold” rating and a $250.00 target price for the company. Finally, Stifel Nicolaus boosted their target price on Align Technology from $205.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, October 23rd. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Align Technology has a consensus rating of “Buy” and a consensus price target of $236.23.
Align Technology (ALGN) traded down $1.24 during trading on Friday, hitting $269.46. The stock had a trading volume of 1,230,855 shares, compared to its average volume of 1,080,000. The firm has a market cap of $21,600.00, a price-to-earnings ratio of 81.90, a P/E/G ratio of 2.13 and a beta of 1.43. Align Technology has a 52 week low of $88.56 and a 52 week high of $273.60.
Align Technology (NASDAQ:ALGN) last posted its earnings results on Thursday, October 26th. The medical equipment provider reported $1.01 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.82 by $0.19. Align Technology had a return on equity of 25.60% and a net margin of 19.98%. The company had revenue of $385.30 million during the quarter, compared to analyst estimates of $359.80 million. During the same period in the previous year, the company earned $0.63 EPS. The company’s revenue for the quarter was up 38.3% compared to the same quarter last year. sell-side analysts anticipate that Align Technology will post 3.67 earnings per share for the current fiscal year.
In related news, CFO John Morici sold 1,500 shares of the business’s stock in a transaction that occurred on Friday, November 24th. The stock was sold at an average price of $255.00, for a total value of $382,500.00. Following the completion of the transaction, the chief financial officer now directly owns 1,544 shares in the company, valued at approximately $393,720. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Emory Wright sold 5,025 shares of the business’s stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $263.68, for a total value of $1,324,992.00. Following the completion of the transaction, the vice president now owns 80,762 shares of the company’s stock, valued at $21,295,324.16. The disclosure for this sale can be found here. Insiders sold a total of 52,849 shares of company stock valued at $13,494,348 over the last quarter. 1.60% of the stock is owned by insiders.
WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Align Technology (ALGN) Share Price” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/19/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-align-technology-algn-share-price.html.
About Align Technology
Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.